Key result
CAC scoring improves 10-year CV risk prediction over SCORE2, outperforming 19 circulating biomarkers.
Why the study?
Does the addition of CAC score or 19 biomarkers improve cardiovascular risk prediction compared to the SCORE2 algorithm in middle-aged adults?
Cohort (n=1,211)
Yes
Does the addition of CAC score or 19 biomarkers improve cardiovascular risk prediction compared to the SCORE2 algorithm in middle-aged adults?
Answers are grounded in this paper and cite their sources.
CAC score significantly improves 10-year cardiovascular risk prediction beyond the SCORE2 algorithm, whereas a panel of 19 biomarkers does not provide similar additive value.
The SCORE2 algorithm is recommended to estimate risk of cardiovascular disease (CVD). Coronary artery calcification (CAC) score is expensive but improves the risk prediction. This study aims to determine and compare the additive value of CAC-score and 19 biomarkers in risk prediction. Traditional cardiovascular (CV) risk factors, CAC-score, and a wide range of biomarkers (including lipids, calcium-phosphate metabolism, troponin, inflammation, kidney function and ankle brachial index (ABI)) were collected from 1211 randomly selected middle-aged men and women in this multicenter prospective cohort in 2009–2010. 10-year follow-up data on CV-events were obtained via the Danish Health Registries. CV-event was defined as stroke, myocardial infarction, hospitalization for heart failure, coronary artery revascularization or death from CVD. The association between SCORE2, CAC-score, biomarkers, and CV-events was assessed using cox proportional hazard rates (HR) and compared using AUC-calculation of ROC-curves. Finally, net reclassification improvement (NRI) was calculated. 92 participants had CV-events. Adjusted for risk factors, CAC-score was significantly associated with events (adjusted HR 1.9 (95%CI:1.1; 3.3), 3.6 (95%CI:1.9; 6.8), and 5. (95%CI:2.6; 10.3) for CAC-score 1–99, CAC-score 100–399 and CAC-score ≥400, respectively. HR for the highest quartile of CRP was 2.3 (95%CI:1.2; 4.5), while none of the remaining biomarkers improved HR. Adjusted for SCORE2, the CAC-score improved AUC (AUC CAC : 0.72, AUC SCORE2 : 0.67, p< 0.01). A combination of selected biomarkers (total cholesterol, low-density lipoprotein, phosphate, troponin, CRP, and creatinine) borderline improved AUC (AUC Biomarkers + SCORE2 : 0.71, AUC SCORE2 : 0.67, p= 0.06). NRI for CAC score was 63 % ( p< 0.0001). CAC-score improved prediction of CV-events, however the selected biomarkers did not. This study aimed to look at a wide range of blood samples to assess if these could improve the risk assessment to the same extent as a coronary artery calcification (CAC) score, as this is known as a strong predictor of cardiovascular diseases (CVD). None of the evaluated markers were able to improve the risk assessment like CAC-score. This study confirmed CAC-score to be a strong predictor of cardiovascular events.
No takes yet. Share an insight, caveat, or question.
Schæffer et al. (2024) conducted a cohort in Cardiovascular disease (n=1,211). Coronary artery calcification (CAC) score vs. SCORE2 algorithm was evaluated on Cardiovascular events (stroke, myocardial infarction, hospitalization for heart failure, coronary artery revascularization or death from CVD) (HR 5.0, 95% CI 2.6-10.3). Coronary artery calcification score improved 10-year cardiovascular event risk prediction over the SCORE2 algorithm, whereas 19 selected biomarkers did not.
Synapse has enriched 10 related papers. Consider them for comparative context: